April 12, 2021
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
Dr Sys Dr Sys
top
Dr Sys
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
Menu
  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY
loading...
Latest Blogs
  • Pfizer, BioNTech request expanded emergency use of Covid-19 vaccine for ages 12-15
  • France widens COVID-19 restrictions, orders schools closed as virus cases surge
  • Johnson & Johnson’s one-shot Covid vaccine cleared for use in the EU
  • FDA staff endorses J&J’s single-shot Covid vaccine for emergency use — clearing way for third vaccine in U.S.
  • Crain’s Health Pulse New York: Virtual Reality, Hybrid Instruction Enliven Medical Education During Pandemic
  • New Covid strain leaves UK isolated, with 1,500 trucks stranded at border
  • Google launches knowledge panels in search results to tackle misinformation about Covid vaccines
  • Smell training could help overcome odor distortions after COVID-19, shows study
  • Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine
  • Moderna says preliminary trial data shows its coronavirus vaccine is more than 94% effective, shares soar
Home U.K.’s health minister
AstraZeneca trial pause is ‘not necessarily’ a setback, British health minister says

AstraZeneca trial pause is ‘not necessarily’ a setback, British health minister says

Posted By: Editorial Teamon: September 09, 2020In: HEALTH, SCIENCENo Comments

The U.K.’s health minister on Wednesday rushed to defend AstraZeneca’s decision to pause a closely-watched coronavirus vaccine trial due to safety concerns, saying that the decision is not necessarily a setback to its development. AstraZeneca announced that the pause was due to a potentially unexplained illness in one of its trials. The pharma giant’s shares […] Read more

Share 0
Tweet
Share
Share
Share

Advertising

services
solutions
vrp

2018 Powered By GroupW

  • HOME
  • EDUCATION
  • HEALTH
  • PEOPLE
  • SCIENCE
  • TECHNOLOGY